epirubicin hydrochloride

This page contains recent news articles, when available, and an overview of epirubicin hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Pharmaceutical Companies Offer Financial Support to Mesothelioma and Other ...  -  ‎Nov 10, 2009‎
Pfizer makes various chemotherapy treatments, and specifically offers assistance to patients using Ellence (epirubicin hydrochloride) for the treatment of ... MesotheliomaHelp.net

… FDA Approval for Epirubicin Hydrochloride Injection; Tentative...  -  Aug 10, 2007
Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Epirubicin Hydrochloride Injection, 2 mg/mL. ... StreetInsider.com - StreetInsider.com (subscription)

… generic drug approvals: Epirubicin Hydrochloride for Injection...  -  Sep 18, 2006
On 19 Sep 2006, the US Food and Drug Administration announced approval of NDA 050807 for Epirubicin Hydrochloride for Injection lyophilized. ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones

… Inc. Announces the Launch of Epirubicin Hydrochloride for Injection...  -  Nov 6, 2006
Mayne Pharma (USA) Inc. Announces the Launch of Epirubicin Hydrochloride for Injection. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Actavis Receives Approval for Irinotecan Hydrochloride...  -  Feb 28, 2008
Epirubicin hydrochloride injection will be offered in 50 mg per 25 ... information. About Epirubicin Hydrochloride Injection Epirubicin hydrochloride ... Pay-Per-View - PR Newswire - HighBeam Research

Epirubicin Hydrochloride for Injection.  -  Jan 8, 2007
Epirubicin Hydrochloride for Injection. Mayne Pharma, Paramus, N.J., (201) 225-5500, is introducing Epirubicin Hydrochloride for Injection (lyophilized) in ... $9.94 - Drug Topics - Alacra Store

… Pharma (USA) Inc. Announces the Launch of Epirubicin Hydrochloride...  -  Nov 6, 2006
Epirubicin Hydrochloride for Injection is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement ... $4.95 - PR Newswire - ECNext

… Cancer; Data show epirubicin hydrochloride injection improves...  -  Jan 1, 2005
2005 JAN 1 - (NewsRx.com & NewsRx.net) -- Results of a study presented at the 27th Annual San Antonio Breast Cancer Symposium show that an Ellence ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Epirubicin hydrochloride injection.(NEW GENERICS)(Brief article)  -  Sep 3, 2007
Epirubicin hydrochloride injection, an anthracycline cytotoxic agent, is available as 2 mg/mL in 50-mg and 200-mg single-dose vials. $4.95 - Drug Topics - ECNext

Epirubicin hydrochloride injection.  -  Sep 3, 2007
Epirubicin hydrochloride injection, an anthracycline cytotoxic agent, is available as 2 mg/mL in 50-mg and 200-mg single-dose vials. ... $9.94 - Drug Topics - Alacra Store

Epirubicin hydrochloride for injection.  -  Oct 23, 2006
Epirubicin hydrochloride for injection. Mayne Pharma, Paramus, N.J., (201) 225-5500, has approval for epirubicin hydrochloride for injection as a component ... $9.94 - Drug Topics - Alacra Store

New and generic drug approvals: Epirubicin Hydrochloride Injection.  -  Aug 18, 2006
On 18 Aug 2006, the US Food and Drug Administration announced the tentative approval of NDA 050807 for Epirubicin Hydrochloride Injection. ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones

Epirubicin hydrochloride for injection.(NEW GENERICS)(Brief article)  -  Oct 23, 2006
Mayne Pharma, Paramus, NJ, (201) 225-5500, has approval for epirubicin hydrochloride for injection as a component of adjuvant therapy in patients with ... $4.95 - Drug Topics - ECNext

Australia: Pharmaceutical Patent Infringement - Interlocutory...  -  May 15, 2008
...injectable ready-to-use solutions containing an anti-tumour anthracycline glycoside, including doxorubicin hydrochloride and epirubicin hydrochloride. ... Mondaq News Alerts - Mondaq News Alerts (Registration)

United Kingdom: Patent litigation – from start to finish (including...  -  Apr 26, 2005
Mayne wished to sell an injectable solution of an anti-cancer drug – Epirubicin hydrochloride. Pharmacia were proprietor of a patent covering Epirubicin ... Mondaq News Alerts - Mondaq News Alerts (Registration)

Australia: Interlocutory Injunctions for Pharmaceutical Patent...  -  Mar 15, 2006
Under that licence, Pfizer manufactures and sells ready-to-use solutions of doxorubicin hydrochloride and epirubicin hydrochloride. ... Mondaq News Alerts - Mondaq News Alerts (Registration)

San Antonio Breast Cancer Symposium.  -  Dec 15, 2006
Ellence (epirubicin hydrochloride injection) is part of a chemotherapy regimen used to treat the early stages of breast cancer when the cancer has spread to ... Free with registration - M2 Presswire - AccessMyLibrary.com

Article: Palladone pulled; FDA examines related opioids.(Food and...  -  Aug 15, 2005
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

APP Receives FDA Approval for Epirubicin HCl Injection.  -  Oct 17, 2007
...today announced approval from US Food and Drug Administration (FDA) to market Epirubicin hydrochloride injection in four dosage forms. ... Free with registration - Business Wire - AccessMyLibrary.com

Pfizer Unit Drops Bid to Block Mayne's Cancer Drug  -  Sep 14, 2006
Mayne's drug is known by its chemical name, epirubicin hydrochloride. Ellence last year generated sales of $73 million in the US and $367 million worldwide. ... Bloomberg

Press Release: Sagent Pharmaceuticals Launches Ceftriaxone, USP, and …  -  Jul 16, 2008
PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately ... phosphate for injection, USP and epirubicin hydrochloride ... Phosphate for Injection ... Pay-Per-View - PR Newswire - HighBeam Research

FDA approves IV epirubicin.(PRODUCTS)(Food and Drug Administration) …  -  Jan 1, 2007
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Free with registration - Internal Medicine News - AccessMyLibrary.com

Food product allergen labels due for overhaul.(NEWS FROM THE FDA) | …  -  Nov 1, 2008
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Gabitril label to warn of seizures.(Neurology) | Article from...  -  Mar 15, 2005
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

GAO: FDA needed broader pool.(POLICY & PRACTICE)(Government …  -  Nov 15, 2008
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Able Laboratories recalls all its drugs.(Brief Article) | Article...  -  Sep 15, 2005
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Abraxis Pharmaceutical Products, Schaumburg, Ill., (847) 413-2075,...  -  Dec 10, 2007
Epirubicin hydrochloride injection will be available in a 2-mg/mL concentration in four volumes: 5 mL and 75 mL (not currently available on the market) and ... Free with registration - Drug Topics - AccessMyLibrary.com

Don't use MRI with neurologic implants.(Rx)(magnetic resonance...  -  Sep 1, 2005
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Loislaw Federal District Court Opinions - PHARMACIA & UPJOHN v. …  -  Aug 17, 2006
...doxorubicin hydrochloride and epirubicin hydrochloride dissolved in a physiologically acceptable aqueous solvent, having a pH adjusted to from 2.5 to ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

FDA panel cites missing key data, nixes mesh cardiac support device.(...  -  Sep 1, 2005
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Article: FDA approves IV epirubicin.(PRODUCTS)(Food and Drug …  -  Jan 1, 2007
...find Internal Medicine News articles. The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated f... Pay-Per-View - Internal Medicine News - HighBeam Research

ASIANET DAILY SUMMARY - JAN 25, 2007.  -  Jan 25, 2007
...that Dong-A Pharmaceutical has been granted a COS(Certificate of Suitability of Monographs of the European Pharmacopoeia) for Epirubicin Hydrochloride, ... $4.95 - AsiaPulse News - ECNext

Less (shar-)pei, more grey(hound).(INDICATIONS)(diet pill for...  -  Feb 15, 2007
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Dong-A Pharmaceutical: Acquisition of European COS of an Active …  -  Jan 24, 2007
...that Dong-A Pharmaceutical has been granted a COS(Certificate of Suitability of Monographs of the European Pharmacopoeia) for Epirubicin Hydrochloride, ... $4.95 - PR Newswire - ECNext

Press Release: San Antonio Breast Cancer Symposium. - M2 Presswire | ...  -  Dec 15, 2006
...and the chemotherapy Ellence (epirubicin hydrochloride injection) will be presented at the San Antonio Breast Cancer Symposium (SABCS) December 14 - 17, ... Pay-Per-View - M2 Presswire - HighBeam Research

FDA approves first artificial implantable heart.(News)(Food and Drug ...  -  Oct 15, 2006
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Article: FDA to regulate tobacco?(POLICY & PRACTICE)(Food and Drug …  -  Mar 15, 2007
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Press Release: PFIZER INC - Research Update. - PR Newswire UK …  -  Dec 15, 2006
15 -- Results of two studies evaluating the hormonal therapy Aromasin(R) (exemestane tablets) and the chemotherapy Ellence(R) (epirubicin hydrochloride ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

Rhino dehorned.(INDICATIONS)(Brief article) | Article from Internal …  -  Apr 15, 2007
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Critics say generics thwarted.(POLICY & PRACTICE)(Brief article) |...  -  Jun 1, 2006
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

0.3% Differin gel.(PRODUCTS)(Brief article) | Article from Internal …  -  Sep 1, 2007
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Press Release: New Data On Pfizer's Aromasin and Ellence to Be …  -  Dec 14, 2006
...the chemotherapy Ellence(R) (epirubicin hydrochloride injection) will be presented at the San Antonio Breast Cancer Symposium (SABCS) December 14 - 17, ... Pay-Per-View - PR Newswire - HighBeam Research

Beef bones, belly rubs passe now.(INDICATIONS)(Brief article) |...  -  May 15, 2007
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

FDA eyes phase IV.(POLICY & PRACTICE)(Food and Drug …  -  May 15, 2006
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Two Brazilian diet supplements contaminated with drugs. | Article...  -  Feb 15, 2006
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Press Release: Dong-A Pharmaceutical: Acquisition of European COS of ...  -  Jan 24, 2007
...that Dong-A Pharmaceutical has been granted a COS(Certificate of Suitability of Monographs of the European Pharmacopoeia) for Epirubicin Hydrochloride, ... Pay-Per-View - PR Newswire - HighBeam Research

Panel favors strict limits on natalizumab's return: the risk managemen...  -  Apr 15, 2006
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

FDA: ibuprofen blocks aspirin's cardioprotection.(Cardiovascular …  -  Oct 1, 2006
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Generic BP drug approved.(PRODUCTS)(blood pressure)(Brief article) | ...  -  Dec 1, 2006
The Food and Drug Administration has approved epirubicin hydrochloride for injection. The drug is indicated for use as a component of adjuvant therapy in ... Pay-Per-View - Internal Medicine News - HighBeam Research

::: ê±´ê°•ì?´ ë³´ì?´ëŠ” 대한민국 대표 ì?˜ë£Œì‹ ë¬¸ 메디컬투ë?°ì?´ :::  -  Jul 12, 2006
...[메디컬투�� 우정헌 기�] �아제약(대표�사 강신호)� 지난 6월 21� 항암제 �료� 'Epirubicin Hydrochloride'� 대해 유럽 COS ��� ��했다고 �혔다. ... 메디컬투��

ë?™ì•„제약, 항암제 ì›?료 유럽 품질ì?¸ì¦? íš?ë“?  -  Jul 13, 2006
...�아제약� 항암제 �료� �피루비신 하�드로�로��드(Epirubicin Hydrochloride) 를 만드는 제조기술과 제품품질� 대해 최근 유럽�약품 품질�합 ��(유럽 COS) ... �로커스





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy